Formulations

Formulations
Product Description

We understand that speed is of the essence when working to deliver a life-changing drug to market. Our experienced clinical formulation development team can support formulation development across a vast range of dosage forms – including oral, ophthalmic and transdermal formulations, as well as injectables, inhaled therapies and more. Whether NCE or 505(b)(2), we can work with our partners to help you rapidly progress your drug from the preclinical stage through to commercial formulation development as part of an integrated process.

Benefits of formulation development with Nanoform

Our rigorous QbD approach to the formulation development of nanoformed drugs can open up new possibilities for drug delivery innovation. Reducing the API’s size down to the nanoscale can enable:

Reproducibly fast dissolution

High drug load

Potential for a simple formulation with less excipients

High physical suspension stability

Enhanced permeability

Novel opportunities for exploring coformulations, in particular dual API formulations

Read more Show less

Nanoform Finland Oy

  • FI
  • 2019
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Other
View company profile
Categories
more categories Show less

Nanoform Finland Oy

  • FI
  • 2019
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Other
View company profile

More Products from Nanoform Finland Oy (3)

  • AI Drug Candidate Screening

    Product AI Drug Candidate Screening

    Our STARMAP® 2.0 platform leverages cutting-edge sparse-data AI to pick winners among candidate molecules that are predicted to be best amenable to CESS®-powered nanoforming and that exhibit optimal production characteristics.

    When existing data alone is not sufficient for generating specific pr...
  • Biologics

    Product Biologics

    Why have we developed our bio nanoparticle technology?

    The biologics industry is expanding rapidly as the potential of biological therapies grows in recognition. The field is also expected to become more versatile as it grows from antibody-focused production to gene and cell therapies, exosomes,...
  • Small Molecules

    Product Small Molecules

    Our multi-patented Controlled Expansion of Supercritical Solutions (CESS®) technology enables the creation of API nanoparticles directly from solution. The process can be applied to most small molecules, with a high success rate of 80-90%.

    CESS® is a bottom-up method of recrystallization that wo...

Nanoform Finland Oy resources (1)

  • Nanoform brochure

    Brochure Nanoform brochure

    Our aim is to improve the lives of patients globally by overcoming drug development and delivery challenges through our game-changing technologies. Enhanced by the most talented minds in physics, AI, biology and engineering, our nanoparticle engineering, formulation and GMP manufacturing services can drive forward your market success and unlock the power of “small".